Zongyang Yu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Landslides and related hazards
Papers in
- Oncology 10
- Lung Cancer Research Studies 3
- Peptidase Inhibition and Analysis 3
-
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 3
- Co-authors
- Ying Chen (2 shared papers)Xiaoyan Qi (2 shared papers)Qiang Xu (1 shared paper)Srikrishnan Siva Subramanian (1 shared paper)Bing Xia (1 shared paper)Lei Zhang (2 shared papers)Xiangyang Dou (1 shared paper)Shuiliang Wang (3 shared papers)
- Journals
- Frontiers in Oncology (4 papers)Translational Lung Cancer Research (2 papers)Clinical & Translational Oncology (1 paper)Annals of Palliative Medicine (1 paper)The Oncologist (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Zongyang Yu
19 papers receiving 296 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 81
- Management, Monitoring, Policy and Law 43
- Oncology 85
- Pulmonary and Respiratory Medicine 94
- Pharmacology 20
Countries citing papers authored by Zongyang Yu
This map shows the geographic impact of Zongyang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongyang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongyang Yu more than expected).
Fields of papers citing papers by Zongyang Yu
This network shows the impact of papers produced by Zongyang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongyang Yu. The network helps show where Zongyang Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zongyang Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 46 | |
| 2 | 2021 | 32 | |
| 3 | 2019 | 31 | |
| 4 | 2019 | 30 | |
| 5 | 2022 | 27 | |
| 6 | 2019 | 25 | |
| 7 | 2022 | 20 | |
| 8 | 2020 | 19 | |
| 9 | 2021 | 15 | |
| 10 | 2020 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2014 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2021 | 4 | |
| 16 | Expression of XIAP and Smac in human non-small-cell lung carcinoma(NSCLC)and the relationship with clinical significance and prognosis | 2014 | 1 |
| 17 | 2024 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2025 | 0 |
About Zongyang Yu
Zongyang Yu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 21 papers that have together received 298 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers), RNA modifications and cancer (3 papers), Peptidase Inhibition and Analysis (3 papers), Cancer-related molecular mechanisms research (2 papers), Fungal Infections and Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (81 citations), Management, Monitoring, Policy and Law (43 citations), Oncology (85 citations), Pulmonary and Respiratory Medicine (94 citations) and Pharmacology (20 citations). Zongyang Yu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Ying Chen, Ying Chen, Xiaoyan Qi, Qiang Xu, Srikrishnan Siva Subramanian, Bing Xia, Lei Zhang, Xiangyang Dou, Shuiliang Wang and Fan Yang. Their work appears in journals such as Frontiers in Oncology, Translational Lung Cancer Research, Clinical & Translational Oncology, Annals of Palliative Medicine and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.